Abnormal regional cerebral blood flow in systemic lupus erythematosus patients with psychiatric symptoms

Journal of Clinical Psychiatry

Volumn 66, Issue 7, 2005, Pages 907-913

  Oda, Kenji ^a,b   Matsushima, Eisuke ^a   Okubo, Yoshiro ^c   Ohta, Katsuya ^a   Murata, Yuji ^a   Koike, Ryuji ^a   Miyasaka, Nobuyuki ^a   Kato, Motoichiro ^d  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Onda daini Hospital   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXAPINE; BROTIZOLAM; CORTICOSTEROID; CYSTEINE ETHYL ESTER TC 99M; ESTAZOLAM; LEVOMEPROMAZINE; LORAZEPAM; MILNACIPRAN; STEROID; TRAZODONE; ZOPICLONE;

ADULT; ANXIETY DISORDER; ARTICLE; BRAIN BLOOD FLOW; BRAIN RADIOGRAPHY; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DELUSIONAL DISORDER; DISEASE CLASSIFICATION; DISSOCIATIVE DISORDER; DOSE RESPONSE; EMOTIONAL DISORDER; FEMALE; HUMAN; MALE; MENTAL DISEASE; MENTAL INSTABILITY; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETERS; SYSTEMIC LUPUS ERYTHEMATOSUS; THALAMUS; VISUAL HALLUCINATION;

EID: 22744431682     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0714     Document Type: Article

References (70)

1. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971;50:85-95
2. Futrell N, Shultz LR, Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology 1992;42: 1649-1657
3. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968;47:337-369
4. McCune WJ, Golbus J. Neuropsychiatric lupus. Rheum Dis Clin North Am 1988; 14:149-167
5. Tola MR, Granieri E, Caniatti L, et al. Systemic lupus erythematosus presenting with neurological disorders. J Neurol 1992;239:61-64
6. Omdal R, Selseth B, Klow NE, et al. Clinical neurological, electrophysiological, and cerebral CT scan findings in systemic lupus erythematosus. Scand J Rheumatol 1989; 18:283-289
7. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979;8:212-221
8. van Dam AP. Diagnosis and pathogenesis of CNS lupus. Rheumatol Int 1991;11:1-11
9. Denburg JA, Behmann SA. Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 kd reactivity. Ann Rheum Dis 1994;53:304-308
10. Devinsky O, Petitio CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli and thrombotic thrombocytopenia purpura. Ann Neurol 1988; 23:380-384
11. Hanly JG, Walsh NM, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992; 19:732-741
12. Waterloo K, Omdal R, Sjoholm H, et al. Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 2001;248:595-602
13. Chinn RJ, Wilkinson ID, Hall-Craggs MA, et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:36-46
14. Coban O, Bahar S, Akman-Demir G, et al. A controlled study of reliability and validity of MRI findings in neuro-Behcet's disease. Neuroradiology 1996;38:312-316
15. Gerber S, Biondi A, Dormont D, et al. Long-term MR follow-up of cerebral lesions in neuro-Behcet's disease. Neuroradiology 1996;38:761-768
16. Guma A, Aguilera C, Acebes J, et al. Meningeal involvement in Behcet's disease: MRI. Neuroradiology 1998;40:512-515
17. Hachulla E, Michon-Pasturel U, Leys D, et al. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus 1998;7:124-131
18. Kozora E, West SG, Kotzin BL, et al. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998;41:41-47
19. Miller DH, Ormerod IE, Gibson A, et al. MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 1987;29:226-231
20. Rovaris M, Inglese M, Viti B, et al. The contribution of fast-FLAIR MRI for lesion detection in the brain of patients with systemic autoimmune diseases. J Neurol 2000;247:29-33
21. Wynne PJ, Younger DS, Khandji A, et al. Radiographic features of central nervous system vasculitis. Neurol Clin 1997; 15:779-804
22. Emmi L, Bramati M, De Cristofaro MT, et al. MRI and SPECT investigations of the CNS in SLE patients. Clin Exp Rheumatol 1993; 11:13-20
23. Kodama K, Okada S, Hino T, et al. Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms. J Neurol Neurosurg Psychiatry 1995;58:307-311
24. Postiglione A, De Chiara S, Soricelli A, et al. Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus. Int J Clin Lab Res 1998;28:34-38
25. Rubbert A, Marienhagen J, Pirner K, et al. Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 1993;36:1253-1262
26. Chen JJ, Yen RF, Kao A, et al. Abnormal regional cerebral blood flow found by technetium-99m ethyl cysteinate dimer brain single photon emission computed tomography in systemic lupus erythematosus patients with normal brain MRI findings. Clin Rheumatol 2002;21: 516-519
27. Huang WS, Chiu PY, Tsai CH, et al. Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT. Rheumatol Int 2002;22;178-181
28. Kao CH, Ho YJ, Lan JL, et al. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum 1999;42:61-68
29. Kao CH, Lan JL, ChangLai SP, et al. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 1999;26:129-134
30. Lin WY, Wang SJ, Yen TC, et al. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement. J Nucl Med 1997;38:1112-1115
31. Hossain AK, Murata Y, Zhang L, et al. Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping. Mov Disord 2003;18:697-703
32. Colamussi P, Giganti M, Cittanti C, et al. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med 1995;22:17-24
33. Falcini F, De Cristofaro MT, Ermini M, et al. Regional cerebral blood flow in juvenile systemic lupus erythematosus: a prospective SPECT study: single photon emission computed tomography. J Rheumatol 1998;25:583-588
34. Kovacs JA, Urowitz MB, Gladman DD, et al. The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. J Rheumatol 1995;22:1247-1253
35. Nossent JC, Hovestadt A, Schonfeld DH, et al. Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum 1991;34:1397-1403
36. Russo R, Gilday D, Laxer RM, et al. Single photon emission computed tomography scanning in childhood systemic lupus erythematosus. J Rheumatol 1998;25:576-582
37. Kushner MJ, Tobin M, Fazekas F, et al. Cerebral blood flow variations in CNS lupus. Neurology 1990;40:99-102
38. Sabbadini MG, Manfredi AA, Bozzolo E, et al. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus 1999;8:11-19
39. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-1277
40. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva, Switzerland: World Health Organization; 1993
41. Carbotte RM, Denburg SD, Denburg JA. Cognitive dysfunction and systemic lupus erythematosus. In: Lahita RG, ed. Systemic Lupus Erythematosus. New York, NY: Churchill Livingstone; 1992:865-881
42. Denburg JA, Carbotte RM, Denburg SD. Neuronal antibodies and cognitive dysfunction in systemic lupus erythematosus. Neurology 1987;37:464-467
43. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-369
44. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state for the clinician. J Psychiatr Res 1975;12:189-198
45. O'Tuama LA, Treves ST. Brain single-photon emission computed tomography for behavior disorders in children. Semin Nucl Med 1993; 23:255-264
46. Friston KJ, Holmes AP, Worsley KJ, et al. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189-210
47. Friston KJ, Holmes AP, Poline JB, et al. Detecting activations in PET and fMRI: levels of inference and power. Neuroimage 1996;40:223-235
48. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. Three-Dimensional Proportional System: An Approach to Cerebral Imaging. New York, NY: Thieme Medical Publishers; 1988
49. Ashburner J, Neelin P, Collins DL, et al. Incorporating prior knowledge into image registration. Neuroimage 1997;6:344-352
50. Zvaifler NJ, Bluestein HG. The pathogenesis of central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 1982; 25:862-866
51. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium. Arthritis Rheum 1996;39: 9-22
52. Grunwald F, Schomburg A, Badali A, et al. 18FDG PET and acetazolamide-enhanced 99m Tc-HMPAO SPET in systemic lupus erythematosus. Eur J Nucl Med 1995;22:1073-1077
53. Szer IS, Miller JH, Rawlings D, et al. Cerebral perfusion abnormalities in children with central nervous system manifestations of lupus detected by single photon emission computed tomography. J Rheumatol 1993;20: 2143-2148
54. Desgranges B, Baron JC, de la Sayette V, et al. The neural substrates of memory systems impairment in Alzheimer's disease: a PET study of resting brain glucose utilization. Brain 1998;121:611-631
55. Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer's disease [letter]. Lancet 1994;344:895
56. Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94
57. Matsuda H, Kitayama N, Ohnishi T, et al. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med 2002;43:304-311
58. Vogt BA, Finch DM, Olson CR. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex 1992;2:435-443
59. Drevets WC, Raichle ME. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull 1992; 28:261-274
60. Kapur S, Meyer J, Wilson AA, et al. Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans. Brain Res 1994;646:292-294
61. Smith DF, Geday J. PET neuroimaging of clomipramine challenge in humans: focus on the thalamus [Erratum in Brain Res 2001;903:269]. Brain Res 2001;892:193-197
62. Byne W, Buchsbaum MS, Mattiace LA, et al. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry 2002;159:59-65
63. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990;47:1023-1028
64. Popken GJ, Bunney WE Jr, Potkin SG, et al. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc Natl Acad Sci U S A 2000;97:9276-9280
65. Young KA, Manaye KF, Liang C, et al. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry 2000; 47:944-953
66. Vasile RG, Sachs G, Anderson JL, et al. Changes in regional cerebral blood flow following light treatment for seasonal affective disorder: responders versus nonresponders. Biol Psychiatry 1997;42:1000-1005
67. Oda K, Okubo Y, Ishida R, et al. Regional cerebral blood flow in depressed patients with white matter magnetic resonance hyperintensity. Biol Psychiatry 2003;53:150-156
68. Awada HH, Mamo HL, Luft AG, et al. Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement. J Neurol Neurosurg Psychiatry 1987;50:1597-1601
69. Miller DD, Andreasen NC, O'Leary DS, et al. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol Psychiatry 2001;49:704-715
70. Nobler MS, Roose SP, Prohovnik I, et al. Regional cerebral blood flow in mood disorders, 5: effects of antidepressant medication in late-life depression. Am J Geriatr Psychiatry 2000;8:289-296